|
|
Volumn 149, Issue 1, 2000, Pages 215-216
|
|
Should reductase inhibitor therapy to lower cholesterol be instituted in the setting of an acute coronary event? [1]
a
a
NONE
(United States)
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ATORVASTATIN;
COLESTYRAMINE;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
LANOSTEROL;
LIPOPROTEIN A;
LOW DENSITY LIPOPROTEIN CHOLESTEROL;
NICOTINIC ACID;
PLACEBO;
PRAVASTATIN;
ACUTE HEART INFARCTION;
CHOLESTEROL BLOOD LEVEL;
CHOLESTEROL SYNTHESIS;
CLINICAL TRIAL;
HEALING;
HUMAN;
HYPERCHOLESTEROLEMIA;
ISCHEMIC HEART DISEASE;
LETTER;
PRIORITY JOURNAL;
SECONDARY PREVENTION;
FEMALE;
FOLLOW-UP STUDIES;
HUMANS;
HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS;
HYPERCHOLESTEROLEMIA;
LIPOPROTEINS, LDL;
MALE;
MYOCARDIAL INFARCTION;
RANDOMIZED CONTROLLED TRIALS;
TREATMENT OUTCOME;
|
|
EID: 0034003329
PISSN: 00219150
EISSN: None
Source Type: Journal
DOI: 10.1016/S0021-9150(99)00411-6 Document Type: Letter |
|
Times cited : (3)
|
|
References (25)
|
